1887

Abstract

The p34 protein [p38, p34, p38(XBL), XBL-I] of bovine leukaemia virus (BLV) activates transcription from the BLV long terminal repeat (LTR) promoter. To analyse the functional properties of this protein, in frame insertions and internal deletions were systematically introduced in a plasmid-encoded copy of the p34 gene. The abilities of wild-type and mutant genes to activate gene expression from the LTR promoter linked to the chloramphenicol acetyltransferase gene and to inhibit trans-activation by the wild-type protein were studied. The trans-activating activity of 14 of the 18 mutants tested was completely abolished, but four mutants each containing a lesion in the internal portion of the polypeptide retained activity. Taken together, these results suggest the presence of an internal region of the polypeptide where structural integrity is less strictly required for the functional activity of this protein. Among the mutants incompetent in the transactivation assay, only two with mutations in the N-terminal region of the polypeptide inhibited trans-activation by the wild-type protein in a dose-dependent manner. These results facilitate understanding of the physiological function of the tax protein family.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-10-2527
1991-10-01
2022-08-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/10/JV0720102527.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-10-2527&mimeType=html&fmt=ahah

References

  1. Burny A., Bruck C., Chantrenne H., Cleuter Y., Dekegel D., Ghysdael J., Kettmann R., Leclercq M., Leunen J., Mammerickx M., Portetelle D. 1980; Bovine leukemia virus: molecular biology and epidemiology. In Viral Oncology pp 231–289 Edited by Klein G. New York: Raven Press;
    [Google Scholar]
  2. Derse D. 1987; Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. Journal of Virology 61:2462–2471
    [Google Scholar]
  3. Friedman A. D., Triezenberg S. J., McKnight S. L. 1988; Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature, London 335:452–454
    [Google Scholar]
  4. Gorman C. M., Merlino G. T., Willingham M. C., Pastan I., Howard B. H. 1982a; The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proceedings of the National Academy of Sciences, U.S.A 79:6777–6781
    [Google Scholar]
  5. Gorman C. M., Moffat L. F., Howard B. H. 1982b; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
  6. Green M., Ishino M., Loewenstein P. M. 1989; Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58:215–223
    [Google Scholar]
  7. Inoue J., Seiki M., Yoshida M. 1986; The second pX product p27X-III of HTLV-I is required for gag gene expression. FEBS Letters 209:187–190
    [Google Scholar]
  8. Itohara S., Sekikawa K. 1987; Molecular cloning of infectious proviral genomes of bovine leukemia virus. Virology 159:158–160
    [Google Scholar]
  9. Itohara S., Tomiyama T., Ushimi C., Sekikawa K. 1988; Cooperative regulation of bovine leukaemia virus gene expression by two overlapping open reading frames in the XBL region. Journal of General Virology 69:797–804
    [Google Scholar]
  10. Katoh I., Yoshikawa Y., Ikawa Y. 1989; Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF. EMBO Journal 8:497–503
    [Google Scholar]
  11. Rice N. R., Simek S. L., Dubois G. C., Showalter S. D., Gilden R. V., Stephens R. M. 1987; Expression of the bovine leukemia virus X region in virus-infected cells. Journal of Virology 61:1577–1585
    [Google Scholar]
  12. Rimsky L., Duc Dodon M., Dixon E. P., Greene W. C. 1989; Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature, Ixmdon 341:453–456
    [Google Scholar]
  13. Rosen C. A., Sodroski J. G., Willems L., Kettmann R., Campbell K., Zaya R., Burny A., Haseltine W. A. 1986; The 3′ region of bovine leukemia virus genome encodes a trans–activator protein. EMBO Journal 5:2585–2589
    [Google Scholar]
  14. Sagata N., Tsuzuku-Kawamura J., Nagayoshi-Aida M., Shimizu F., Imagawa K., Ikawa Y. 1985a; Identification and some biochemical properties of the major XBL gene product of bovine leukemia virus. Proceedings of the National Academy of Sciences, U.S.A 82:7879–7883
    [Google Scholar]
  15. Sagata N., Yasunaga T., Tsuzuku-Kawamura J., Ohishi K., Ogawa Y., Ikawa Y. 1985b; Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proceedings of the National Academy of Sciences, U.S.A 82:677–681
    [Google Scholar]
  16. Sakurai M., Strominger J. L. 1988; B-cell-specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB gene. Proceedings of the National Academy of Sciences, U.S.A 85:6909–6913
    [Google Scholar]
  17. Shima H., Takano M., Shimotohno K., Miwa M. 1986; Identification of p26Xb and p24Xb of human T-cell leukemia virus type II. FEBS Letters 209:289–294
    [Google Scholar]
  18. Slamon D. J., Shimotohno K., Cline M. J., Golde D. W., Chen I. S. Y. 1984; Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science 226:61–65
    [Google Scholar]
  19. Smith M. R., Greene W. C. 1990; Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes and Development 4:1875–1885
    [Google Scholar]
  20. Wachsman W., Cann A. J., Williams J. L., Slamon D. J., Souza L., Shah N. P., Chen I. S. Y. 1987; HTLV x gene mutants exhibit novel transcriptional regulatory phenotypes. Science 235:674–677
    [Google Scholar]
  21. Willems L., Chen G., Portetelle D., Mamoun R., Burny A., Kettmann R. 1989; Structural and functional characterization of mutants of the bovine leukemia virus transactivator protein p34. Virology 171:615–618
    [Google Scholar]
  22. Willems L., Heremans H., Chen G., Portetelle D., Billiau A., Burny A., Kettmann R. 1990; Cooperation between bovine leukemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO Journal 9:1577–1581
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-10-2527
Loading
/content/journal/jgv/10.1099/0022-1317-72-10-2527
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error